Both authors contributed equally to this work.
Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis
Version of Record online: 19 APR 2012
© 2012 The Authors, Addiction Biology © 2012 Society for the Study of Addiction
Volume 17, Issue 3, pages 505–512, May 2012
How to Cite
Chamorro, A.-J., Marcos, M., Mirón-Canelo, J.-A., Pastor, I., González-Sarmiento, R. and Laso, F.-J. (2012), Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis. Addiction Biology, 17: 505–512. doi: 10.1111/j.1369-1600.2012.00442.x
- Issue online: 19 APR 2012
- Version of Record online: 19 APR 2012
Figure S1 Funnel plot with pseudo 95% confidence limits for studies included in the meta-analysis of the association of A118G Opioid µ-receptor polymorphism with relapse rates after naltrexone treatment in patients with alcohol dependence.
Table S1 Baseline demographics, clinical characteristics, and outcomes of naltrexone-treated patients with alcohol dependence in studies included in our meta-analysis.
|ADB_442_sm_tableS1.doc||51K||Supporting info item|
|ADB_442_sm_figureS1.tif||1606K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.